The Harvard Medical School Diabetes Update 2024

Identifying Various Types of Diabetes in Clinical Practice

1. Is It Type 1 Diabetes, Type 2 Diabetes, or Something Else? – Miriam Udler, MD, PhD

2. Are All Pathophysiological Abnormalities in Patients with Type 2 Diabetes the Same? – Osama Hamdy, MD, PhD

3. Q and A and Practical Recommendations – Miriam Udler, MD, PhD & Osama Hamdy, MD, PhD

Medical Nutrition Management in Diabetes and Obesity

4. Pros and Cons of Most Popular Diets – Moe Schlachter, MS, RD, LD, CDCES

5. Current Dietary Recommendations in Diabetes and Obesity – Laura Andromalos, MS, RD, RN, CSOWM, CDCES

6. Q and A and Practical Recommendations – Laura Andromalos, MS, RD, RN, CSOWM, CDCES & Moe Schlachter, MS, RD, LD, CDCES

Prescribing Exercise to Patients with Diabetes

7. Exercise Recommendations in Type 2 Diabetes and Obesity – Roeland J.W. Middelbeek, MD

8. A Practical Exercise Session Demonstration – Jacqueline I. Shahar, MEd, RCEP, CDCES

9. Q and A and Practical Recommendations – Roeland J.W. Middelbeek, MD & Jacqueline I. Shahar, MEd, RCEP, CDCES

Special Lecture

10. Improving Diabetes Care for All: A Daunting but Crucial Task in Clinical Practice – A. Enrique Caballero, MD

Obesity Management in the Patient with Diabetes

1. Pharmacological Management: Individualizing Therapy – W. Scott Butsch, MD, MSc

2. Surgical Management: What Intervention and When? – Philip R. Schauer, MD

3. Q and A and Practical Recommendations – W. Scott Butsch, MD, MSc & Philip R. Schauer, MD

Dyslipidemia Management in Diabetes

4. Strategies to Achieve LDL-Cholesterol Goals in the Patient with Diabetes – Om P. Ganda, MD

5. What’s Next after Achieving LDL-Cholesterol Targets? An Update – Janet Lo, MD, MMSc

6. Q and A and Practical Recommendations – Om P. Ganda, MD & Janet Lo, MD, MMSc

Hypertension Management in the Patient with Diabetes

7. Clinical Evaluation of the Patient with Hypertension and Diabetes – Anand Vaidya, MD, MMSc

8. Strategies to Achieve Blood Pressure Targets – John P. Forman, MD, MSc

9. Q and A and Practical Recommendations – Anand Vaidya, MD, MMSc & John P. Forman, MD, MSc

Special Lecture

10. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A 2024 Vision – Nezam Afdhal, MD

Technology Advances in Diabetes Care

1. Continuous Glucose Monitoring: A 2024 Vision – Devin Steenkamp, MD

2. Insulin Pumps, Closing the Loop: Where Do We Stand? – Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP

3. Q and A and Practical Recommendations – Devin Steenkamp, MD & Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP

Management of Diabetes in the Elderly Population

4. Type 2 Diabetes in the Elderly: Key Special Considerations – Marie E. McDonnell, MD

5. Selection, Intensification, and Deintensification of Pharmacological Therapies – Medha Munshi, MD

6. Q and A and Practical Recommendations – Marie E. McDonnell, MD & Medha Munshi, MD

Addressing Diversity in Diabetes Care

7. The Impact of Personal, Social, Financial, and Cultural Factors in Diabetes Care – Rocio Pereira, MD

8. Practical Strategies to Address Social Determinants of Health in Clinical Practice – A. Enrique Caballero, MD

9. Q and A and Practical Recommendations – Rocio Pereira, MD & A. Enrique Caballero, MD

Special Lecture

10. Emotional Distress and Psychological Factors in the Patient with Diabetes – Mary deGroot, PhD

Evaluation of Cardiovascular and Renal Status and Risk in Diabetes Care

1. CV Disease in the Patient with Diabetes: Practical Assessment – Jorge Plutzky, MD

2. Evaluation of Renal Function Status and Risk in Diabetes – Robert Stanton, MD

3. Q and A and Practical Recommendations – Jorge Plutzky, MD & Robert Stanton, MD

Pharmacological Management of Type 2 Diabetes: Traditional Medications

4. Traditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors) – Deborah J. Wexler, MD, MPH

5. Insulin Therapy in the Patient with Diabetes – Guillermo Umpierrez, MD, CDCES, FACE, MACP

6. Q and A and Practical Recommendations – Deborah J. Wexler, MD, MPH & Guillermo E. Umpierrez, MD, CDCES, FACE, MACP

Pharmacological Management of Type 2 Diabetes: Newer Medications

7. SGLT-2 Inhibitors: An Update – Silvio E. Inzucchi, MD

8. GLP-1 Receptor Agonists: An Update – Juan Frias, MD

9. Mineralocorticoid Receptor Antagonists: Role in Diabetes Care – George L. Bakris, MD, FAHA, FASN

10. Q and A and Practical Recommendations – Silvio E. Inzucchi, MD & George L. Bakris, MD, FAHA, FASN